National and Kapodistrian University of Athens
Διερεύνηση της συχνότητας των διαταραχών έκκρισης της αλδοστερόνης σε νέο-διαγνωσμένους υπερτασικούς ασθενείς: αξιολόγηση της ανταπόκρισης των υπερτασικών ασθενών με πρωτοπαθή υπεραλδοστερονισμό στην χορήγηση στοχευμένης αγωγής με ανταγωνιστές των υποδοχέων της αλδοστερόνης
Abstract
dc:descriptionBackground: Primary aldosteronism (PA) is the most common endocrine cause of arterial hypertension. Despite the increasing incidence of hypertension worldwide, the true prevalence of PA in hypertension was only recently recognized.Objective: To estimate the prevalence of PA in patients at different stages of hypertension based on a newly developed screening-diagnostic overnight test.Design: Prospective study. Subjects: Hypertensive patients (n=265) at stage I (n=100), II (n= 88) and III (n=77) of hypertension. A group of 103 patients with essential hypertension without PA was used as controls.Methods: PA diagnosis was based on a combined screening-diagnostic overnight test, the Dexamethasone-Captopril-Valsartan Test (DCVT) that evaluates aldosterone secretion after pharmaceutical blockade of angiotensin-II and adrenocorticotropic hormone. DCVT was performed in all participants independently of the basal aldosterone to renin ratio (ARR). Results: The calculated upper normal limits for post-DCVT aldosterone levels [3ng/dl (85 pmol/l)] and post-DCVT ARR [0.32 ng/dl/μU/ml (9pmol/IU)] from controls, were applied together to establish PA diagnosis. Using these criteria PA was confirmed in 80 of 265 (30%) hypertensives. The prevalence of PA was: 21% (21/100) in stage I, 33% (29/88) in stage II, and 39% (30/77) in stage III. Serum K+ levels were negatively correlated and urinary K+ was positively correlated in PA patients with post-DCVT ARR (r=-0.349, p<0.01, and r=0.27, p<0.05 respectively).Conclusion: DCVT revealed that PA is a highly prevalent cause of hypertension. DCVT could be employed as a diagnostic tool in all subjects with arterial hypertension of unknown cause.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2022
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Voulgaris, Nikolaos
- Βούλγαρης, Νικόλαος
Subjects
dc:subject × 19- Αρτηριακή υπέρταση
- Πρωτοπαθής υπεραλδοστερονισμός
- Αλδοστερόνη
- ΔΡΑΣΤΙΚΟΤΗΣ ΡΕΝΙΝΗΣ ΠΛΑΣΜΑΤΟΣ
- Ρενίνη
- Ανταγωνιστές υποδοχέων αλδοστερόνης
- Δευτεροπαθής Υπέρταση
- primary aldosteronism
- Plasma renin - aldosterone activity
- Aldosterone
- Mineralocorticoid receptor (MR)
- Secondary hypertension
- Aldosterone to Renin ratio
- Κλινική Ιατρική
- Ιατρική και Επιστήμες Υγείας
- Ενδοκρινολογία, Διαβήτης και Μεταβολισμός
- Clinical Medicine
- Medical and Health Sciences
- Endocrinology, Diabetes and Metabolism
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/52642